Ex-EKF investee Trellus confirms intention to list on AIM
18th May 2021 10:28
(Sharecast News) - EKF Diagnostics' former investree, connected health technology company Trellus Health, confirmed its intention to seek admission of its shares to trading on AIM.
Read moreSunday share tips: Trident Royalties, EKF Diagnostics
9th May 2021 18:47
(Sharecast News) - The Financial Mail on Sunday's Midas column recommends buying stock in Trident Royalties, touting soaring metals' prices and "bright" prospects.
Read moreSunday share tips: N Brown, Foxtons
17th Jan 2021 19:56
(Sharecast News) - The Financial Mail on Sunday's Midas column touted a raft of shares which it expected would benefit from the fight against obesity as well as the associated, and sometimes fatal, health risks.
Read moreEKF partner Kantaro gets FDA authorisation for Covid-19 test
26th Nov 2020 14:53
(Sharecast News) - Point-of-care company EKF Diagnostics updated the market on developments at its partner Kantaro Biosciences on Thursday, confirming that it had received Emergency Use Authorization from the US Food and Drug Administration (FDA) for 'COVID-SeroKlir', its semi-quantitative SARS-CoV-2 IgG antibody test kit.
Read moreEKF Diagnostics trades ahead of FY expectations
9th Nov 2020 10:18
(Sharecast News) - Point-of-care business EKF Diagnostics said on Monday that it looked set to trade ahead of market expectations for the full year.
Read moreEKF Diagnostics secures new orders for Covid-19 sample collection devices
22nd Oct 2020 09:43
(Sharecast News) - Point-of-care business EKF Diagnostics has received orders for its Covid-19 sample collection devices from two new customers.
Read moreEKF Diagnostics receives further orders for Covid-19 testing kits
5th Aug 2020 09:16
(Sharecast News) - Point-of-care business EKF Diagnostics has received an initial order worth more than £3.0m to supply its PrimeStore MTM collection device to a private sector partner for use in a Covid-19 testing programme.
Read moreEKF Diagnostics signs distribution deal with Tosoh Europe
5th May 2020 15:23
(Sharecast News) - Point-of-care company EKF Diagnostics has signed a three-year distribution agreement with Tosoh Europe, part of chemical supply and specialty materials company Tosoh Corporation, for the distribution of its 'Quo-Test' HbA1c Analyzer in the Middle East and Africa.
Read moreEKF Diagnostics to supply collection device for Covid-19 testing
29th Apr 2020 10:59
(Sharecast News) - Point-of-care business EKF Diagnostics Holdings has signed an agreement with Source BioScience to supply a novel patented sample collection device for its growing Covid-19 testing service.
Read moreEKF Diagnostics shares slide as firm reports middling progress
13th Mar 2019 15:06
(Sharecast News) - Point-of-care business EKF Diagnostics Holdings reported a 2% improvement in its full-year revenue on Wednesday, to £42.5m.
Read moreEKF Diagnostics blood analyser to begin US sales
22nd Jan 2019 13:29
(Sharecast News) - Point-of-care business EKF Diagnostics Holdings announced on Tuesday that, further to its private label distribution agreement with McKesson Medical-Surgical, sales of the McKesson Consult Hb analyser were expected next month, following the full launch of the product in the United States.
Read moreEKF Diagnostics flags budget-beating year
9th Jan 2017 08:13
(ShareCast News) - Point-of-care business EKF Diagnostics Holdings announced on Monday that trading in the final quarter of the year ended 31 December was "materially better than budget", and that the overall performance for the year will exceed revised market forecasts, which themselves were recent
Read moreEKF Diagnostics sees FY revenues, earnings ahead of market views
7th Nov 2016 12:07
(ShareCast News) - AIM-listed point-of-care business EKF Diagnostics said on Monday that revenues and adjusted earnings for the year to the end of December are likely to be ahead of current market forecasts. EKF said early trading in the fourth quarter has again been "materially higher" than budg
Read moreEKF Diagnostics boosts earnings in first half
12th Sep 2016 10:41
(ShareCast News) - Point-of-care business EKF Diagnostics Holdings announced its unaudited interim results for the six months to 30 June on Monday, ahead of market expectations. The AIM-traded firm said it has an installed base of over 90,000 analysers globally and manufactures over 56 million tests
Read morePanmure maintains 'buy' on EKF Diagnostics
6th Jul 2016 10:44
(ShareCast News) - EKF Diagnostics shares rose on Wednesday as Panmure Gordon reiterated a 'buy' rating and target price of 14p after an upbeat trading update. In a first half trading update, EKF said sales and adjusted EBITDA are ahead of market expectations for the six months ended 30 June 2016.
Read more